Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 18:25:34 +0200Tue, 11 Jun 2024 15:33:00 +0200Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/pyzchivaHuman medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/pyzchivaTue, 11 Jun 2024 15:33:00 +0200Human medicinePyzchiva : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6183-en.pdfPyzchiva : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6183-en.pdfTue, 11 Jun 2024 12:42:00 +0200Human medicine